Starting
Initialising…
0%
ABL1
Final classification
VUS
ABL1 c.908-16G>A · p.?
ABL1

The ABL1 c.908-16G>A (p.?) variant has been reported in ClinVar as likely benign with single-submitter review status.

Gene
ABL1
Transcript
NM_005157.4
HGVS · transcript:coding
NM_005157.4:c.908-16G>A
Consequence
N/A
GRCh38
chr9:130872844 G>A
GRCh37
chr9:133748231 G>A
Basis gene-specific framework lacked a usable explicit final combination framework, so generic ACMG/AMP 2015 final-combination rules were applied as fallback; applied criteria: PM2 supporting, BP7 supporting; combination = 1 supporting + 1 supporting benign, which maps to VUS because the evidence is conflicting.
gene-specific framework lacked a usable explicit final combination framework, so generic ACMG/AMP 2015 final-combination rules were applied as fallback; applied criteria: PM2 supporting, BP7 supporting; combination = 1 supporting + 1 supporting benign, which maps to VUS because the evidence is conflicting.
Classification rationale
PM2 BP7 VUS
ABL1 c.908-16G>A

The ABL1 c.908-16G>A (p.?) variant has been reported in ClinVar as likely benign with single-submitter review status.1 This variant is present at very low frequency in population databases, with allele frequencies of 0.00082% in gnomAD v2.1 and 0.00169% in gnomAD v4.1, both below the 0.1% PM2 threshold used in this workflow.2 SpliceAI predicts no significant splice effect for this intronic change, with a maximum delta score of 0.01, which supports a benign computational interpretation.3

PM2 + BP7 VUS
Gene diagram · NM_005157.4 · variants mapped to exon structure
ABL1 NM_005157.4
Fetching transcript structure from UCSC…
Applied criteria · 2 met · select any tile
Met
Not met
Not assessed
N/A
Strength very strong supporting
Pathogenic evidence
PVS
PS
PM
PP
Benign evidence
BA
BS
BP
Rationale
Select a criterion.
Sources
Evidence used
    Gaps remaining
      Rule
      Research & evidence
      Population frequency
      gnomAD v4.1 screenshot
      gnomAD v4.1
      gnomAD v2.1 screenshot
      gnomAD v2.1
      v4.1
      This variant is present in gnomAD v4.1 (AF= 1.68647e-05; MAF= 0.00169%, 27/1600974 alleles, homozygotes = 0) and has highest observed frequency in the European (non-Finnish) population (AF= 2.22007e-05; MAF= 0.00222%, 26/1171134 alleles, homozygotes = 0); grpmax FAF= 1.544e-05.
      v2.1
      This variant is present in gnomAD v2.1 (AF= 8.1714e-06; MAF= 0.00082%, 2/244756 alleles, homozygotes = 0) and has highest observed frequency in the South Asian population (AF= 3.372e-05; MAF= 0.00337%, 1/29656 alleles, homozygotes = 0).
      Allele frequency by ancestry
      three datasets · side by side
      gnomAD v4.1
      0.0017% · 27 / 1,600,974
      0 hom · FAF 0.0015%
      European (non-Finnish)
      26 / 1,171,134
      0.0022%
      South Asian
      1 / 90,118
      0.0011%
      + 8 not observed (Remaining individuals, Admixed American, European (Finnish), Amish, East Asian, Middle Eastern, Ashkenazi Jewish, African/African American)
      gnomAD v2.1
      0.00082% · 2 / 244,756
      0 hom
      South Asian
      1 / 29,656
      0.0034%
      European (non-Finnish)
      1 / 110,438
      0.00091%
      + 6 not observed (African/African American, Admixed American, Ashkenazi Jewish, East Asian, European (Finnish), Remaining individuals)
      ClinVar screenshot
      ClinVar
      This variant has been reported in ClinVar as Likely benign (1 clinical laboratory). (ClinVarID = 4763580)
      SpliceAI screenshot
      In silico
      SpliceAI predicts no significant splice impact for this variant (max delta score = 0.01).
      Functional No data
      No calibrated functional assay or RNA evidence was identified for this variant.
      OncoKB ↗
      COSMIC screenshot
      COSMIC
      Somatic evidence
      COSMIC
      This variant has not previously been reported in somatic cancers (COSMIC).
      Hotspots
      This variant does not lie in a statistically significant cancer hotspot.
      COSMIC ↗
      Sources & reference links
      6Sources
      ClinVar
      gnomAD v2.1
      gnomAD v4.1
      SpliceAI
      OncoKB
      COSMIC
      Triaged references · 1 PMID not cited in assessment
      28492532 ↗ Sherloc: a comprehensive refinement of the ACMG-AMP variant classification criteria. CLINVAR